Urinary Metabolic Profile of Patients with Transfusion-Dependent β-Thalassemia Major Undergoing Deferasirox Therapy

Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia major (β-TM). The aim of this study was to analyze the renal function and urine metabolomic profile of β-TM patients undergoing transfusions and deferasirox (DFX) therapy, in order to better character...

Full description

Saved in:

Bibliographic Details
Main Authors:	Giovanna Capolongo (Author), Miriam Zacchia (Author), Amerigo Beneduci (Author), Silvia Costantini (Author), Patrizia Cinque (Author), Anna Spasiano (Author), Giuseppina De Luca (Author), Maria Enrica Di Pietro (Author), Paolo Ricchi (Author), Francesco Trepiccione (Author), Giovambattista Capasso (Author), Aldo Filosa (Author)
Format:	Book
Published:	Karger Publishers, 2020-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes
by: Ricchi P, et al.
Published: (2015)

Impact of Local and Systemic Factors on Kidney Dysfunction in Bardet-Biedl Syndrome
by: Miriam Zacchia, et al.
Published: (2017)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
by: Kontoghiorghe CN, et al.
Published: (2016)

Switching from Deferasirox Dispersible Tablets to Deferasirox Film-Coated Tablets: Is There an Effect on Ferritin Levels in Children and Adolescents with Transfusion-Dependent Anemia?
by: Esra Arslantaş, et al.
Published: (2024)

Deferasirox adherence in patients with thalassemia: Exploring the association with patient knowledge and ferritin levels
by: Reem Ali Shaker, et al.
Published: (2024)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
by: Alessandra F. Perna, et al.
Published: (2020)

Transfusion-induced hemoglobinopathy in patients of beta-thalassemia major
by: Sanjeev K Gupta, et al.
Published: (2011)

Osteoporosis in transfusion-dependent thalassemia: A major contributor to morbidity
by: Sneha Bhosle, et al.
Published: (2024)

Detection of endocrine disorders in young children with multi-transfused thalassemia major
by: Ramadan A. Mahmoud, et al.
Published: (2021)

Comparison of Deferiprone to Deferasirox and Deferoxamine to Cardiac and Hepatic T2* MRI in Thalassemia Patients: Evidence-based Case Report
by: Pustika Amalia Wahidiyat, et al.
Published: (2018)

Oxidative Stress and Antioxidant Status in Adult Patients with Transfusion-Dependent Thalassemia: Correlation with Demographic, Laboratory, and Clinical Biomarkers
by: Antonella Meloni, et al.
Published: (2024)

Evaluation of Transfusion-Related Infections in Patients with Beta Thalassemia Major in Southeast Turkey
by: Esra Pekpak Şahinoğlu, et al.
Published: (2023)

Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles
by: Mahya Mobinikhaledi, et al.
Published: (2024)

Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook
by: Melluso A, et al.
Published: (2023)

Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 - 2014
by: Mehrnoush Kosaryan, et al.
Published: (2015)

Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 - 2014
by: Mehrnoush Kosaryan, et al.
Published: (2015)

Physical growth in children with transfusion-dependent thalassemia
by: Harish K Pemde, et al.
Published: (2011)

Deferasirox in thalassemia: a comparative study between an innovator drug and its copy among a sample of Iraqi patients
by: Aqil M. Daher, et al.
Published: (2019)

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
by: Shahla Ansari, et al.
Published: (2017)

Pengaruh Deferasirox Terhadap Kadar T4 dan TSH Pada B-Thalassemia Mayor dengan Kadar Ferritin Tinggi
by: Dewi Ratih P, et al.
Published: (2016)

Stable Luminescent Poly(Allylaminehydrochloride)-Templated Copper Nanoclusters for Selectively Turn-Off Sensing of Deferasirox in β-Thalassemia Plasma
by: Hung-Ju Lin, et al.
Published: (2021)

Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions
by: Chalmers AW, et al.
Published: (2016)

Efficacy and Side Effects of Deferasirox and Deferiprone for Thalasemia Major in Children
by: Asti Y. Rindarwati, et al.
Published: (2016)

Two trade names of deferasirox (Osveral® and Exjade®) in reduction of iron overload parameters in major beta-thalassemia patients: A randomized open labeled clinical trial
by: Mohammadreza Rafati, et al.
Published: (2022)

Le rappresentazioni planimetriche di Villa Adriana tra XVI e XVIII secolo Ligorio, Contini, Kircher, Gondoin, Piranes
by: Cinque, Giuseppina Enrica
Published: (2017)

Nature and severity of dental malocclusion in children suffering from transfusion-dependent (-thalassemia major
by: Waqar Jeelani, et al.
Published: (2021)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
by: Taher AT, et al.
Published: (2016)

Occult Kidney Dysfunction in Children With Transfusion-Dependent Thalassemia
by: Nurwahida Mohd Zikre, et al.
Published: (2021)

Exploring Denosumab for osteoporosis in patients with transfusion-dependent thalassemia
by: Sneha Bhosle, et al.
Published: (2024)

Exploring Denosumab for osteoporosis in patients with transfusion-dependent thalassemia
by: Sneha Bhosle, et al.
Published: (2024)

Leukocyte telomere length in patients with transfusion-dependent thalassemia
by: Nithita Nanthatanti, et al.
Published: (2020)

What regulates hepcidin in poly-transfused β-Thalassemia Major: Erythroid drive or store drive?
by: Richa Chauhan, et al.
Published: (2014)

Evaluation of Hepatic Enzymes in major β-thalassemic Patients using Deferasirox
by: Ahmed Yahya Dallal Bashi, et al.
Published: (2022)

Assessing Psychological Disorders in Turkish Adolescents with Transfusion-Dependent Thalassemia
by: Aylin Yetim Şahin, et al.
Published: (2024)

Heart involvement in transfusion-dependent beta-thalassemia with conventional echocardiography
by: Hossein Esfahani, et al.
Published: (2021)

Predictors of pulmonary artery hypertension in transfusion dependent patients with thalassemia
by: Vineeta Gupta, et al.
Published: (2022)

Decision-making about gene therapy in transfusion dependent thalassemia
by: Maa-Ohui Quarmyne, et al.
Published: (2022)

COVID-19 vaccination in pediatric population with transfusion dependent thalassemia
by: Vineeta Singh, et al.
Published: (2022)

Development of Clinical Guideline of Blood Transfusion Process in Children with Thalassemia
by: Sedigheh Khanjari, et al.
Published: (2015)

Development of Clinical Guideline of Blood Transfusion Process in Children with Thalassemia
by: Sedigheh Khanjari, et al.
Published: (2015)